{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:43:32Z","timestamp":1784864612684,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cell Biology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejcb.2024.151457","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T09:03:44Z","timestamp":1726650224000},"page":"151457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Insulin receptor substrate 1 is a novel member of EGFR signaling in pancreatic cells"],"prefix":"10.1016","volume":"103","author":[{"given":"Tam\u00e1s","family":"Tak\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"L\u00e1szl\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lmos","family":"Tilajka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianna","family":"Nov\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Buday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virag","family":"Vas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejcb.2024.151457_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-018-0616-2","article-title":"Randomized, phase I\/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma","volume":"11","author":"Abdel-Wahab","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejcb.2024.151457_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bj3270209","article-title":"Insulin receptor\/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting","volume":"327","author":"Bailyes","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejcb.2024.151457_bib3","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1158\/0008-5472.CAN-12-3775","article-title":"EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain etastasis","volume":"73","author":"Breindel","year":"2013","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ejcb.2024.151457_bib4","first-page":"1","article-title":"Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression","volume":"8","author":"Cai","year":"2017","journal-title":"Nat. Commun. 2017"},{"key":"10.1016\/j.ejcb.2024.151457_bib5","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1158\/1078-0432.CCR-17-2262","article-title":"Dual inhibition of IGF-1R and ErbB3 enhances the activity of gemcitabine and nab-paclitaxel in preclinical models of pancreatic cancer","volume":"24","author":"Camblin","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejcb.2024.151457_bib6","doi-asserted-by":"crossref","first-page":"E7303","DOI":"10.1073\/pnas.1803598115","article-title":"Deep mutational analysis reveals functional trade-offs in the sequences of EGFR autophosphorylation sites","volume":"115","author":"Cantor","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejcb.2024.151457_bib7","article-title":"Targeting the IGF-1\/IGF-1R signaling in uveal melanoma inhibits cell survival, cell migration and reduces tumor growth","volume":"64","author":"Chattopadhyay","year":"2023","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejcb.2024.151457_bib8","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1158\/0008-5472.CAN-05-2858","article-title":"Epidermal Growth Factor Induces Insulin Receptor Substrate-2 in Breast Cancer Cells via c-Jun NH2-Terminal Kinase\/Activator Protein-1 Signaling to Regulate Cell Migration","volume":"66","author":"Cui","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejcb.2024.151457_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.844028","article-title":"The Intricate Crosstalk Between Insulin and Pancreatic Ductal Adenocarcinoma: A Review From Clinical to Molecular","volume":"10","author":"Deng","year":"2022","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.ejcb.2024.151457_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1158\/1055-9965.EPI-19-1315","article-title":"Insulin-like growth factor-1 receptor expression and disease recurrence and survival in patients with resected pancreatic ductal adenocarcinoma","volume":"29","author":"Du","year":"2020","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ejcb.2024.151457_bib11","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1021\/acs.biochem.8b00084","article-title":"EGF Regulates the Interaction of Tks4 with Src through Its SH2 and SH3 Domains","volume":"57","author":"D\u00fclk","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejcb.2024.151457_bib12","first-page":"1039","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science (1979)"},{"key":"10.1016\/j.ejcb.2024.151457_bib13","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1210\/endo.142.7.8283","article-title":"Tyr612 and Tyr632 in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells","volume":"142","author":"Esposito","year":"2001","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.ejcb.2024.151457_bib14","first-page":"1577","article-title":"A hepatocyte growth factor receptor (Met)\u2212insulin receptor hybrid governs hepatic glucose metabolism","volume":"17","author":"Fafalios","year":"2011","journal-title":"Nat. Med. 2011"},{"issue":"1","key":"10.1016\/j.ejcb.2024.151457_bib15","first-page":"1","article-title":"NT157 has antineoplastic effects and inhibits IRS1\/2 and STAT3\/5 in JAK2V617F-positive myeloproliferative neoplasm cells","volume":"5","author":"Fenerich","year":"2020","journal-title":"Signal Transduct. Target. Ther. 2020"},{"key":"10.1016\/j.ejcb.2024.151457_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.biophys.37.032807.125829","article-title":"Structure-Based View of Epidermal Growth Factor Receptor Regulation","volume":"37","author":"Ferguson","year":"2008","journal-title":"Annu Rev. Biophys."},{"key":"10.1016\/j.ejcb.2024.151457_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/annonc\/mdv027","article-title":"A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial","volume":"26","author":"Fuchs","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejcb.2024.151457_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1432-1327.2001.01831.x","article-title":"Involvement of insulin receptor substrates in epidermal growth factor induced activation of phosphatidylinositol 3-kinase in rat hepatocyte primary culture","volume":"268","author":"Fujioka","year":"2001","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.ejcb.2024.151457_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"key":"10.1016\/j.ejcb.2024.151457_bib20","doi-asserted-by":"crossref","first-page":"T69","DOI":"10.1530\/JME-17-0311","article-title":"40 YEARS OF IGF1: IGF1 receptor signaling pathways","volume":"61","author":"Hakuno","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ejcb.2024.151457_bib21","article-title":"Insulin Receptor in Pancreatic Cancer\u2014Crown Witness in Cross Examination","volume":"Vol. 13","author":"Heckl","year":"2021","journal-title":"Cancers 2021"},{"key":"10.1016\/j.ejcb.2024.151457_bib22","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2013.03.032","article-title":"Phase 2 Study of Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy in Patients With Resectable Pancreatic Cancer","volume":"86","author":"Herman","year":"2013","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys."},{"key":"10.1016\/j.ejcb.2024.151457_bib23","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.1158\/0008-5472.CAN-10-0391","article-title":"Differential mechanisms of acquired resistance to insulin-like growth factor-I receptor antibody therapy or to a small-molecule inhibitor, BMS-754807, in a human rhabdomyosarcoma model","volume":"70","author":"Huang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejcb.2024.151457_bib24","first-page":"5185","article-title":"IRS-1 regulates proliferation, invasion and metastasis of pancreatic cancer cells through MAPK and PI3K signaling pathways","volume":"11","author":"Huang","year":"2018","journal-title":"Int J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.ejcb.2024.151457_bib25","first-page":"1","article-title":"ER\u03b1\/PR crosstalk is altered in the context of the ER\u03b1 Y537S mutation and contributes to endocrine therapy-resistant tumor proliferation","volume":"9","author":"Huggins","year":"2023","journal-title":"npj Breast Cancer 2023"},{"key":"10.1016\/j.ejcb.2024.151457_bib26","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1677\/erc.1.01279","article-title":"Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy","volume":"13","author":"Hutcheson","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejcb.2024.151457_bib27","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1158\/1535-7163.MCT-13-0842","article-title":"The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer","volume":"13","author":"Ibuki","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.ejcb.2024.151457_bib28","first-page":"172","article-title":"Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells","volume":"95","author":"Jones","year":"2006","journal-title":"Br. J. Cancer 2006"},{"issue":"7073","key":"10.1016\/j.ejcb.2024.151457_bib29","first-page":"168","article-title":"A quantitative protein interaction network for the ErbB receptors using protein microarrays","volume":"439","author":"Jones","year":"2005","journal-title":"Nature 2005"},{"key":"10.1016\/j.ejcb.2024.151457_bib30","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.3390\/ijms231810382","article-title":"Dual inhibition of EGFR and IGF-1R signaling leads to enhanced antitumor efficacy against esophageal squamous cancer","volume":"23","author":"Kang","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.ejcb.2024.151457_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3018","article-title":"ErbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines","volume":"13","author":"Knowlden","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejcb.2024.151457_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-007-9763-9","article-title":"Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: Implication for Gefitinib ('Iressa\u2019) response and resistance","volume":"111","author":"Knowlden","year":"2008","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.ejcb.2024.151457_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.annonc.2019.09.004","article-title":"Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)","volume":"31","author":"Kundranda","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejcb.2024.151457_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/kjm2.12652","article-title":"Repressing IRS1\/2 by NT157 inhibits the malignant behaviors of ovarian cancer through inactivating PI3K\/AKT\/mTOR pathway and inducing autophagy","volume":"39","author":"Li","year":"2023","journal-title":"Kaohsiung J. Med Sci."},{"key":"10.1016\/j.ejcb.2024.151457_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01732-6","article-title":"KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities","volume":"39","author":"Luchini","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejcb.2024.151457_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pan.2019.11.011","article-title":"Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer","volume":"20","author":"McCleary-Wheeler","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.ejcb.2024.151457_bib37","article-title":"Targeting PI3K pathway in pancreatic ductal adenocarcinoma: rationale and progress","volume":"Vol. 13","author":"Mehra","year":"2021","journal-title":"Cancers 2021"},{"key":"10.1016\/j.ejcb.2024.151457_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/1097-4652(200101)186:1<35::AID-JCP1003>3.0.CO;2-X","article-title":"IRS-1 and IRS-2 are recruited by TrkA receptor and oncogenic TRK-T1","volume":"186","author":"Miranda","year":"2001","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.ejcb.2024.151457_bib39","first-page":"1","article-title":"NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells","volume":"12","author":"de Miranda","year":"2022","journal-title":"Sci. Rep. 2022"},{"key":"10.1016\/j.ejcb.2024.151457_bib40","article-title":"Mechanism of resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and a potential treatment strategy","volume":"Vol. 7","author":"Nagano","year":"2018","journal-title":"Cells 2018"},{"key":"10.1016\/j.ejcb.2024.151457_bib41","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2174\/1389450115666141125123003","article-title":"EGFR as a potential target for the treatment of pancreatic cancer: dilemma and controversies","volume":"15","author":"Nedaeinia","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejcb.2024.151457_bib42","doi-asserted-by":"crossref","first-page":"22005","DOI":"10.18632\/oncotarget.8013","article-title":"Activation of the IGF1R pathway potentially mediates acquired resistance to mutant-selective 3rd-generation EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejcb.2024.151457_bib43","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1002\/cncr.28744","volume":"120","author":"Philip","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ejcb.2024.151457_bib44","first-page":"1399","article-title":"Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma","volume":"28","author":"Pryczynicz","year":"2008","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ejcb.2024.151457_bib45","first-page":"1","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J. Hematol. Oncol. 2020"},{"key":"10.1016\/j.ejcb.2024.151457_bib46","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.celrep.2017.02.013","article-title":"Autocrine IGF1 signaling mediates pancreatic tumor cell dormancy in the absence of oncogenic drivers","volume":"18","author":"Rajbhandari","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejcb.2024.151457_bib47","doi-asserted-by":"crossref","first-page":"22583","DOI":"10.1074\/jbc.M002915200","article-title":"Transactivation of the EGF receptor mediates IGF-1-stimulated Shc phosphorylation and ERK1\/2 activation in COS-7 cells","volume":"275","author":"Roudabush","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejcb.2024.151457_bib48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5483\/BMBRep.2015.48.6.157","article-title":"Insulin activates EGFR by stimulating its interaction with IGF-1R in low-EGFR-expressing TNBC cells","volume":"48","author":"Shin","year":"2015","journal-title":"BMB Rep."},{"key":"10.1016\/j.ejcb.2024.151457_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/bj2630553","article-title":"Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors","volume":"263","author":"Soos","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejcb.2024.151457_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097016","article-title":"Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis","volume":"9","author":"Subramani","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejcb.2024.151457_bib51","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e16764","article-title":"A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-Met co-expressing metastatic pancreatic adenocarcinoma (PDAC)","volume":"38","author":"Turk","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejcb.2024.151457_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1249-2","article-title":"Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors","volume":"15","author":"Urtasun","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejcb.2024.151457_bib53","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1128\/MCB.21.7.2269-2280.2001","article-title":"Association of insulin receptor substrate 1 (IRS-1) Y895 with Grb-2 mediates the insulin signaling involved in IRS-1-deficient brown adipocyte mitogenesis","volume":"21","author":"Valverde","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejcb.2024.151457_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.gendis.2022.03.002","article-title":"Drugging IGF-1R in cancer: New insights and emerging opportunities","volume":"10","author":"Wang","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.ejcb.2024.151457_bib55","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2147\/IJN.S394133","article-title":"Selenium biofortification enhanced miR167a expression in broccoli extracellular vesicles inducing apoptosis in human pancreatic cancer cells by targeting IRS1","volume":"18","author":"Wang","year":"2023","journal-title":"Int J. Nanomed."},{"issue":"1","key":"10.1016\/j.ejcb.2024.151457_bib56","first-page":"1","article-title":"Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun. 2020"},{"key":"10.1016\/j.ejcb.2024.151457_bib57","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"Vol. 9","author":"Wee","year":"2017","journal-title":"Cancers 2017"},{"key":"10.1016\/j.ejcb.2024.151457_bib58","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001250051387","article-title":"The insulin signalling system and the IRS proteins","volume":"40","author":"White","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejcb.2024.151457_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.683788","article-title":"Targeting growth factor signaling pathways in pancreatic cancer: towards inhibiting chemoresistance","volume":"11","author":"Xelwa","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.ejcb.2024.151457_bib60","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.str.2022.05.007","article-title":"How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor","volume":"30","author":"Xu","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.ejcb.2024.151457_bib61","doi-asserted-by":"crossref","first-page":"36235","DOI":"10.18632\/oncotarget.8827","article-title":"Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejcb.2024.151457_bib62","article-title":"LINC00638 promotes the progression of non-small cell lung cancer by regulating the miR-541-3p\/IRS1\/PI3K\/Akt axis","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"issue":"7457","key":"10.1016\/j.ejcb.2024.151457_bib63","first-page":"166","article-title":"Temporal regulation of EGF signalling networks by the scaffold protein Shc1","volume":"499","author":"Zheng","year":"2013","journal-title":"Nature 2013"},{"key":"10.1016\/j.ejcb.2024.151457_bib64","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/j.febslet.2006.08.068","article-title":"Transactivation of epidermal growth factor receptor by insulin-like growth factor 1 requires basal hydrogen peroxide","volume":"580","author":"Zhou","year":"2006","journal-title":"FEBS Lett."}],"container-title":["European Journal of Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933524000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933524000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:00:41Z","timestamp":1732986041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171933524000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0171933524000748"],"URL":"https:\/\/doi.org\/10.1016\/j.ejcb.2024.151457","relation":{},"ISSN":["0171-9335"],"issn-type":[{"value":"0171-9335","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin receptor substrate 1 is a novel member of EGFR signaling in pancreatic cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejcb.2024.151457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151457"}}